drugset / Trial / NCT03712475

Pharmacokinetics of Two Formulation of Pregabalin

NCT03712475

RandomizedParallel-groupOpen-labelTreatment

Summary

A Randomized, Single-Dose, Parallel-Group Study to Evaluate the Pharmacokinetic Profiles of Two Formulations of Pregabalin after Oral Administration in Healthy Volunteers under Fasting Conditions

Timeline

Start
2018-01-19
Primary completion
2018-09-16
Completion
2018-12-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule Oral